| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2025 | Mar 17, 2025 | aTYR PHARMA INC | Director | Buy | 91.3 | +3,750 | 62.50% | ✗ | $15K |
| Mar 1, 2019 | Mar 4, 2019 | Aptevo Therapeutics Inc. | Officer | Sell | 27.5 | -2,710 | -2.41% | ✗ | $4.3K |
| Mar 9, 2018 | Mar 13, 2018 | Aptevo Therapeutics Inc. | Officer | Sell | 27.5 | -2,282 | -2.16% | ✗ | $7.1K |
| Aug 1, 2017 | Aug 3, 2017 | Aptevo Therapeutics Inc. | Officer | Sell | 26.3 | -10,076 | -12.83% | ✗ | $18.4K |
| Mar 1, 2017 | Mar 13, 2017 | Aptevo Therapeutics Inc. | Officer | Sell | 26.3 | -8,558 | -8.45% | ✗ | $15.8K |
| Feb 3, 2017 | Feb 8, 2017 | Aptevo Therapeutics Inc. | Officer | Sell | 26.3 | -5,922 | -27.17% | ✗ | $11.4K |